Toho Holdings Co., Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2012; Provides Earnings Guidance for Fiscal 2013
May 08, 2012
Share
Toho Holdings Co., Ltd. announced consolidated earnings results for the year ended March 31, 2012. For the year, the company reported net sales of JPY 1,108,089 million, operating income of JPY 14,073 million, ordinary income of JPY 17,732 million, net income of JPY 10,766 million or JPY 142.24 per share as compared to net sales of JPY 1,059,612 million, operating income of JPY 5,839 million, ordinary income of JPY 9,481 million, net income of JPY 7,283 million for the same period prior year.
For fiscal 2013, the company expects net sales of JPY 1,140,000 million, operating income of JPY 15,700 million, ordinary income of JPY 18,400 million, net income of JPY 10,400 million or JPY 141.20 per share.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.